Ebola case in the US by June 30?

No human decision-makers control whether an Ebola case appears in the US; the outcome is governed by low-probability natural importation under strong existing US screening, entry restrictions, and non-airborne transmission. CDC assessments already rate importation risk extremely low over the next three months, and the remaining 15-day window makes any undetected case + domestic confirmation vanishingly unlikely. Base rates for similar distant outbreaks producing a US case in under three weeks are near zero, with no recent behavioral signals or catalysts suggesting otherwise.

Rules require a laboratory-confirmed Ebola case reported in US territory by 11:59 PM ET June 30, 2026 (post-May 15 market open), with CDC as primary source or overwhelming credible consensus. CDC statements as of June 14 confirm zero such cases linked to the DRC/Uganda outbreak, with one infected American treated abroad instead; enhanced screening and low importation risk make any confirmation in the remaining 15 days structurally implausible. No RESOLVER UPDATES override the criteria, and smart-money alignment with No further supports the side.

High weekly volume ($290K) and consensus pricing at 85¢ No with meaningful liquidity indicate real trader agreement rather than stale illusion. Smart-money whales lean No (larger stake on that side) with no high-confidence opposition, and recent price action shows only minor drift consistent with low-risk consensus hold. No thin-book signals, whale reversal, or contradictory sibling flow detected.